For decades, the diagnosis of multiple myeloma required evidence of end-organ damage characterized by myeloma-defining events ...

monoclonal gammopathy of undetermined significance (MGUS) and smoldering multiple myeloma (SMM), with a subset of patients progressing from MGUS through SMM to multiple myeloma. 1 Many people with ...

Monoclonal gammopathy of undetermined significance (MGUS) is not cancer. There’s a small risk it can become cancer. Out of every 100 people with MGUS, each year, 1 or 2 of them will get cancer from ...

Multiple myeloma is part of the spectrum of diseases ranging from MGUS to plasma cell leukemia, and similar to MGUS, is characterized by proliferation of a plasma cell clone and subsequent ...

"We are really pleased to have our abstract accepted by ASCO, it indicates the novelty and importance of our TeloView® based MRD applications and the impact we hope to have on patients and physicians ...

Birmingham researchers have received £230k from Cancer Research Horizons to develop a prototype test for monitoring people with MGUS (monoclonal gammopathy of unknown significance), a precursor to ...